Jeffrey M. Farma, MD, FACS
- Request Appointment
- Clinical Locations
- About
- Education and Training
- Patient Stories
- Research Profile
- Publications
- Ratings
Clinical Locations
Primary Location
Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111
Secondary Location
Temple University Hospital – Main Campus
3509 N. Broad Street
Boyer Pavilion, 6th Floor
Philadelphia, PA 19140
About
Co-Director, Melanoma and Skin Cancer Program
Chief, Division of General Surgery
Professor, Department of Surgical Oncology
Program Director, Complex General Surgical Oncology Fellowship
NCCN, Non-Melanoma Skin Cancer Panel Member
Specialties
Treatment Focus
Colorectal cancer, melanoma, sarcoma, minimally invasive and robotic surgery, isolated limb infusion for in-transit melanoma and extremity sarcomas.
Research Program
Key Awards
 |
| Surgery |
Treatment Philosophy
It is an honor to be part of the staff of the Fox Chase Cancer Center. My initial exposure occurred during a rotation as a Temple University Medical School student at Fox Chase that led me down the path of Surgical Oncology. As a native Philadelphian, I am privileged to work at such an esteemed institution. I was enthralled then by the dedicated care of the staff in dealing with all aspects of treating patients diagnosed with cancer, and I hope to continue this throughout my career at Fox Chase.
I trained in general surgery at Temple University Hospital. During my fellowship at the National Cancer Institute in Bethesda, Maryland, I learned from experts in the field of surgical oncology about clinical trial design, experimental therapeutics and the importance of bench-to-bedside research to progress the fight against cancer. I encountered patients with very complex problems, and the greatest lesson I learned was there are always treatment options, utilizing all different types of techniques including radiation, chemotherapy and surgery.
My clinical surgical oncology fellowship at the Moffitt Cancer Center in Tampa, Florida has provided me with an extensive understanding of the multidisciplinary approach to treating patients with cancer. One of the greatest benefits of a cancer center like Fox Chase is the close knit group of expert physicians from all specialties that are constantly interacting and providing the highest level of care using the most innovative strategies to treat all aspects of cancer. I have developed a particularly strong interest in the surgical and multimodal treatment of patients with Melanoma, Sarcoma and Colorectal cancers, using traditional surgery, regional therapies, and minimally invasive techniques. I have the operative expertise to perform many of these complex procedures using laparoscopic, robotic, and TAMIS (transanal minimally invasive surgery) techniques and have had advanced training in using newest techniques. I am an expert in the treatment of colorectal cancer including; sphincter sparing and nerve sparing resections, and treating patients with hereditary colorectal cancer syndromes.
For melanoma and sarcoma that has regional spread in the extremities I offer a minimally invasive technique call Isolated Limb Infusion, and perform minimally invasive inguinal lymph node dissections.
Most importantly, I hold my patients as my number one priority. I will spend as much time as necessary educating, answering questions and providing guidance for each individual patient to help them throughout each stage of treatment. I believe in candid discussions, where both the patients and families goals and expectations are openly communicated. We will work together as a team to formulate a treatment plan. My personal goal is to treat and care for every patient with the same compassion and honesty as if they were a friend or family member.
Follow on Twitter: @jeffreyfarma
Education and Training
Educational Background
- Fellow, Surgical Oncology, Moffitt Cancer Center, Tampa, FL, 2009
- Administrative Chief Resident, Department of Surgery, Temple University Hospital, Philadelphia, PA, 2007
- Chief Resident, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, 2006
- Fellow, Surgical Oncology, Surgery Branch, National Cancer Institute, NIH, Bethesda, MD, 2005
- Resident, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, 2003
- MD, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, 2000
Certifications
- American Board of Surgery
Memberships
- National Comprehensive Cancer Network (NCCN)
- Non-Melanoma Skin Cancer Panel
- Academy of Master Surgeon Educators - Associate Member
- American College of Surgeons
- American College of Surgeons Oncology Group (ACOSOG)
- American Radium Society
- American Society of Colon and Rectal Surgeons
- Association of Academic Surgery - Candidate Member
- College of Physicians of Philadelphia
- Connective Tissue Oncology Society (CTOS)
- Eastern Cooperative Oncology Group
- Metropolitan Philadelphia American College of Surgeons
- Midwest Melanoma Partnership (MMP)
- North American Neuroendocrine Tumor Society
- Pennsylvania Medical Society
- Philadelphia Academy of Surgery
- Society of Laparoendoscopic Surgeons
- Society of Surgical Oncology, vice chair of the Complex General Surgical Oncology Program Directors Committee
- Society for Surgery of the Alimentary Tract
- Society of University Surgeon
- Surgical Biology Club III
Honors & Awards
- Philadelphia Magazine Top Doctors, 2018-20
- 2020 AAS/Colombian Surgical Association International Visiting Professorship Award, 2019
- Society of Surgical Oncology European Society of Surgical Oncology Observership, 2019
- Castle Connelly national list of Top Doctors®, Regional Top Doctor 2014-17
- Humanitarian Award, Melanoma Research Foundation, 2016
- 2015 American College of Surgeons Traveling Fellowship to Germany, 2014
- Alpha Omega Alpha, National Medical Honor Society, Epsilon Chapter- Honorary Member, 2014
- H. Lee Moffitt Cancer Center 2008 Fellow’ Education Research Symposium, Best Clinical Poster Presentation, 2008
- Temple University Surgery Resident Research Symposium Award, 2007
- H. Taylor Caswell Award, Department of Surgery Teaching Award for outstanding Chief Surgical Resident, 2007
- ASCO Foundation Merit Award, 2005
Patient Stories
James "Cy" Young
Melanoma
Brenda Vorters
GIST (Gastrointestinal Stromal Tumor)
Brenda Vorters
GIST (Gastrointestinal Stromal Tumor)
Found by Accident
In 2014, I had just retired and was looking forward to traveling with my husband, Leonard. I had been dealing with a multiday headache that just kept getting worse, and at one point, I passed out. I woke up four days later to learn that I had suffered a massive brain bleed. As a result of this, my doctors ordered a complete CT scan to get an idea of what was going on.
Robert Roy
Colorectal Cancer
Robert Roy
Colorectal Cancer
I have been an EMT and a firefighter for 35 years. It started out as a hobby when I volunteered in high school, and it turned into a career. Thankfully, the job has kept me in good health and helped me remain in shape.
However, through my job, I had seen people at the end stage of their cancer journey. Whenever I saw a case like that, a little thought popped up in the back of my mind that it could be me one day. So, when I was diagnosed with colon cancer, I was nervous.
Stephanie Heart
Melanoma
Stephanie Heart
Melanoma
It was malignant melanoma on my great left toe. I was terrified. Dr. Farma was gentle and kind about it and I was sobbing.
Joseph Daly
Brain & Spinal Tumors
Joseph Daly
Brain & Spinal Tumors
I’m an active guy. I like to fish, play golf, travel, dance, and go off-roading. When something goes wrong, rather than sitting around feeling bad, I do anything in my power to remedy the situation. In 2013, this philosophy was severely tested when I was diagnosed with a rare cancer.
Pages
Research Profile
Research Program
Research Interests
- Melanoma: Molecular profiling, outcomes research, clinical trials, immunotherapy
- Colorectal: Molecular and imaging profiling for rectal cancer, outcomes research, clinical trials, quality of life
- Sarcoma
Publications
Selected Publications
Miura JT, Kroon HM, Beasley GM, Mullen D, Farrow NE, Mosca PJ, Lowe MC, Farley CR, Kim Y, Naqvi SMH, Potdar A, Daou H, Sun J, Farma JM, Henderson MA, Speakman D, Serpell J, Delman KA, Mark Smithers B, Coventry BJ, Tyler DS, Thompson JF, Zager JS. Long-Term Oncologic Outcomes After Isolated Limb Infusion for Locoregionally Metastatic Melanoma: An International Multicenter Analysis. Annals of surgical oncology, 2019. PubMed
Moten AS, Movva S, von Mehren M, Wu H, Esnaola NF, Reddy SS, Farma JM. Granular cell tumor experience at a comprehensive cancer center. J Surg Res, 226:1-7, 2018. PubMed
Goel N, Manstein SM, Ward WH, DeMora L, Smaldone MC, Farma JM, Uzzo RG, Esnaola NF. Does the Surgical Apgar Score predict serious complications after elective major cancer surgery? Journal of Surgical Research, 231:242-7, 2018.
Jakub JW, Terando AM, Sarnaik A, Ariyan CE, Faries MB, Zani S Jr, Neuman HB, Wasif N, Farma JM, Averbrook BJ, Bilimoria KY, Jake Allred JB, Suman VJ, Grotz TE, Zendejas B, Wayne JD, Tyler DS. Training High-Volume Melanoma Surgeons to Perform a Novel Minimally Invasive Inguinal Lymphadenectomy: Report of a Prospective Multi-Institutional Trial. Journal of the American College of Surgeons. November 2015.
Schatz TP, Nassif MO, Farma JM. Extensive portal venous gas: Unlikely etiology and outcome. Int J Surg Case Rep. December 2014.
Yeo H, Niland J, Milne D, ter Veer A, Bekail-Saab T, Farma JM, Lai L, Skibber JM, Small W Jr, Wilkinson N, Schrag D, Weiser MR, Incidence of minimally invasive colorectal cancer surgery at national comprehensive cancer network centers. Journal of the National Cancer Institute. December 2014.
Singla S, Papavasiliou P, Powers B, Gaughan J, von Mehren M, Watson JC, Farma JM. Challenges in Treatment of Angiosarcoma: A Single Institution Experience. The American Journal of Surgery. April 2014.
Johnson ME, Zhu F, Li T, Wu H, Galloway TJ, Farma JM,. Perlis C Turaka A,. Absolute Lymphocyte Count: a Potential Prognostic Factor for Merkel Cell Carcinoma. Journal of the American Academy of Dermatology. March 2014.
Yeo H, Niland J, Milne D, Veer AT, Bekaii-Saab T, Farma JM, Lai L, Skibber J, Small W, Wilkenson N, Schrag D, Weiser M. Incidence of Minimally Invasive Colorectal Cancer Surgery at National Comprehensive Cancer Network Centers. Journal of the National Cancer Institute. Accepted for publication. January 2014.
Keller D, Thomay AA, Gaughan J, Wu H, Farma JM. Outcomes in Patients with Mucosal Melanomas. Journal of Surgical Oncology. October 2013.
Chen KT, Papavasiliou P, Edwards K, Zhu F, Perlis C, Wu H, Turaka A, Berger A, Farma JM. A better prognosis for merkel cell carcinoma of unknown primary origin. American Journal of Surgery. July 2013.
Arrangoiz R, Papavasiliou P, Siripuapu V, Li T, Watson JC, Hoffman JP, Farma JM, Partial stomach-partitioning gastrojejunostomy as an alternative for palliation in patients with malignant gastric or duodenal outlet obstruction. American Journal of Surgery. May 2013.
Nitzkorski, James, Willis, A, Farma JM, Zhu F, Nick D, Sigurdson, E. Association of race and socioeconomic status and outcomes with patients with rectal cancer. Ann Surg Oncol. January 2013.
Chen KT, Olszanski A, Farma JM. Donor transmission of melanoma following renal transplant. Case Reports in Transplantation. November 2012.
Farma JM, Zager JS, Barnica-elvir V, Puleo CA, Marzban SS, Rollison DE, Messina JL, Sondak VK. A collision of diseases: chronic lymphocytic leukemia discovered during lymph node biopsy for melanoma. Ann Surg Oncol. November 2012.
Additional Publications
Dr. Jeffery Farma on PubMed
Clinical Locations
Primary Location
Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111
Secondary Location
Temple University Hospital – Main Campus
3509 N. Broad Street
Boyer Pavilion, 6th Floor
Philadelphia, PA 19140
Co-Director, Melanoma and Skin Cancer Program
Chief, Division of General Surgery
Professor, Department of Surgical Oncology
Program Director, Complex General Surgical Oncology Fellowship
NCCN, Non-Melanoma Skin Cancer Panel Member
Treatment Focus
Colorectal cancer, melanoma, sarcoma, minimally invasive and robotic surgery, isolated limb infusion for in-transit melanoma and extremity sarcomas.
Research Program
Key Awards
|
| Surgery |
Treatment Philosophy
It is an honor to be part of the staff of the Fox Chase Cancer Center. My initial exposure occurred during a rotation as a Temple University Medical School student at Fox Chase that led me down the path of Surgical Oncology. As a native Philadelphian, I am privileged to work at such an esteemed institution. I was enthralled then by the dedicated care of the staff in dealing with all aspects of treating patients diagnosed with cancer, and I hope to continue this throughout my career at Fox Chase.
I trained in general surgery at Temple University Hospital. During my fellowship at the National Cancer Institute in Bethesda, Maryland, I learned from experts in the field of surgical oncology about clinical trial design, experimental therapeutics and the importance of bench-to-bedside research to progress the fight against cancer. I encountered patients with very complex problems, and the greatest lesson I learned was there are always treatment options, utilizing all different types of techniques including radiation, chemotherapy and surgery.
My clinical surgical oncology fellowship at the Moffitt Cancer Center in Tampa, Florida has provided me with an extensive understanding of the multidisciplinary approach to treating patients with cancer. One of the greatest benefits of a cancer center like Fox Chase is the close knit group of expert physicians from all specialties that are constantly interacting and providing the highest level of care using the most innovative strategies to treat all aspects of cancer. I have developed a particularly strong interest in the surgical and multimodal treatment of patients with Melanoma, Sarcoma and Colorectal cancers, using traditional surgery, regional therapies, and minimally invasive techniques. I have the operative expertise to perform many of these complex procedures using laparoscopic, robotic, and TAMIS (transanal minimally invasive surgery) techniques and have had advanced training in using newest techniques. I am an expert in the treatment of colorectal cancer including; sphincter sparing and nerve sparing resections, and treating patients with hereditary colorectal cancer syndromes.
For melanoma and sarcoma that has regional spread in the extremities I offer a minimally invasive technique call Isolated Limb Infusion, and perform minimally invasive inguinal lymph node dissections.
Most importantly, I hold my patients as my number one priority. I will spend as much time as necessary educating, answering questions and providing guidance for each individual patient to help them throughout each stage of treatment. I believe in candid discussions, where both the patients and families goals and expectations are openly communicated. We will work together as a team to formulate a treatment plan. My personal goal is to treat and care for every patient with the same compassion and honesty as if they were a friend or family member.
Follow on Twitter: @jeffreyfarma
Education
Educational Background
- Fellow, Surgical Oncology, Moffitt Cancer Center, Tampa, FL, 2009
- Administrative Chief Resident, Department of Surgery, Temple University Hospital, Philadelphia, PA, 2007
- Chief Resident, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, 2006
- Fellow, Surgical Oncology, Surgery Branch, National Cancer Institute, NIH, Bethesda, MD, 2005
- Resident, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, 2003
- MD, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, 2000
Certifications
- American Board of Surgery
Memberships
- National Comprehensive Cancer Network (NCCN)
- Non-Melanoma Skin Cancer Panel
- Academy of Master Surgeon Educators - Associate Member
- American College of Surgeons
- American College of Surgeons Oncology Group (ACOSOG)
- American Radium Society
- American Society of Colon and Rectal Surgeons
- Association of Academic Surgery - Candidate Member
- College of Physicians of Philadelphia
- Connective Tissue Oncology Society (CTOS)
- Eastern Cooperative Oncology Group
- Metropolitan Philadelphia American College of Surgeons
- Midwest Melanoma Partnership (MMP)
- North American Neuroendocrine Tumor Society
- Pennsylvania Medical Society
- Philadelphia Academy of Surgery
- Society of Laparoendoscopic Surgeons
- Society of Surgical Oncology, vice chair of the Complex General Surgical Oncology Program Directors Committee
- Society for Surgery of the Alimentary Tract
- Society of University Surgeon
- Surgical Biology Club III
Honors & Awards
- Philadelphia Magazine Top Doctors, 2018-20
- 2020 AAS/Colombian Surgical Association International Visiting Professorship Award, 2019
- Society of Surgical Oncology European Society of Surgical Oncology Observership, 2019
- Castle Connelly national list of Top Doctors®, Regional Top Doctor 2014-17
- Humanitarian Award, Melanoma Research Foundation, 2016
- 2015 American College of Surgeons Traveling Fellowship to Germany, 2014
- Alpha Omega Alpha, National Medical Honor Society, Epsilon Chapter- Honorary Member, 2014
- H. Lee Moffitt Cancer Center 2008 Fellow’ Education Research Symposium, Best Clinical Poster Presentation, 2008
- Temple University Surgery Resident Research Symposium Award, 2007
- H. Taylor Caswell Award, Department of Surgery Teaching Award for outstanding Chief Surgical Resident, 2007
- ASCO Foundation Merit Award, 2005
Research Profile
Research Interests
- Melanoma: Molecular profiling, outcomes research, clinical trials, immunotherapy
- Colorectal: Molecular and imaging profiling for rectal cancer, outcomes research, clinical trials, quality of life
- Sarcoma
Publications
Selected Publications
Miura JT, Kroon HM, Beasley GM, Mullen D, Farrow NE, Mosca PJ, Lowe MC, Farley CR, Kim Y, Naqvi SMH, Potdar A, Daou H, Sun J, Farma JM, Henderson MA, Speakman D, Serpell J, Delman KA, Mark Smithers B, Coventry BJ, Tyler DS, Thompson JF, Zager JS. Long-Term Oncologic Outcomes After Isolated Limb Infusion for Locoregionally Metastatic Melanoma: An International Multicenter Analysis. Annals of surgical oncology, 2019. PubMed
Moten AS, Movva S, von Mehren M, Wu H, Esnaola NF, Reddy SS, Farma JM. Granular cell tumor experience at a comprehensive cancer center. J Surg Res, 226:1-7, 2018. PubMed
Goel N, Manstein SM, Ward WH, DeMora L, Smaldone MC, Farma JM, Uzzo RG, Esnaola NF. Does the Surgical Apgar Score predict serious complications after elective major cancer surgery? Journal of Surgical Research, 231:242-7, 2018.
Jakub JW, Terando AM, Sarnaik A, Ariyan CE, Faries MB, Zani S Jr, Neuman HB, Wasif N, Farma JM, Averbrook BJ, Bilimoria KY, Jake Allred JB, Suman VJ, Grotz TE, Zendejas B, Wayne JD, Tyler DS. Training High-Volume Melanoma Surgeons to Perform a Novel Minimally Invasive Inguinal Lymphadenectomy: Report of a Prospective Multi-Institutional Trial. Journal of the American College of Surgeons. November 2015.
Schatz TP, Nassif MO, Farma JM. Extensive portal venous gas: Unlikely etiology and outcome. Int J Surg Case Rep. December 2014.
Yeo H, Niland J, Milne D, ter Veer A, Bekail-Saab T, Farma JM, Lai L, Skibber JM, Small W Jr, Wilkinson N, Schrag D, Weiser MR, Incidence of minimally invasive colorectal cancer surgery at national comprehensive cancer network centers. Journal of the National Cancer Institute. December 2014.
Singla S, Papavasiliou P, Powers B, Gaughan J, von Mehren M, Watson JC, Farma JM. Challenges in Treatment of Angiosarcoma: A Single Institution Experience. The American Journal of Surgery. April 2014.
Johnson ME, Zhu F, Li T, Wu H, Galloway TJ, Farma JM,. Perlis C Turaka A,. Absolute Lymphocyte Count: a Potential Prognostic Factor for Merkel Cell Carcinoma. Journal of the American Academy of Dermatology. March 2014.
Yeo H, Niland J, Milne D, Veer AT, Bekaii-Saab T, Farma JM, Lai L, Skibber J, Small W, Wilkenson N, Schrag D, Weiser M. Incidence of Minimally Invasive Colorectal Cancer Surgery at National Comprehensive Cancer Network Centers. Journal of the National Cancer Institute. Accepted for publication. January 2014.
Keller D, Thomay AA, Gaughan J, Wu H, Farma JM. Outcomes in Patients with Mucosal Melanomas. Journal of Surgical Oncology. October 2013.
Chen KT, Papavasiliou P, Edwards K, Zhu F, Perlis C, Wu H, Turaka A, Berger A, Farma JM. A better prognosis for merkel cell carcinoma of unknown primary origin. American Journal of Surgery. July 2013.
Arrangoiz R, Papavasiliou P, Siripuapu V, Li T, Watson JC, Hoffman JP, Farma JM, Partial stomach-partitioning gastrojejunostomy as an alternative for palliation in patients with malignant gastric or duodenal outlet obstruction. American Journal of Surgery. May 2013.
Nitzkorski, James, Willis, A, Farma JM, Zhu F, Nick D, Sigurdson, E. Association of race and socioeconomic status and outcomes with patients with rectal cancer. Ann Surg Oncol. January 2013.
Chen KT, Olszanski A, Farma JM. Donor transmission of melanoma following renal transplant. Case Reports in Transplantation. November 2012.
Farma JM, Zager JS, Barnica-elvir V, Puleo CA, Marzban SS, Rollison DE, Messina JL, Sondak VK. A collision of diseases: chronic lymphocytic leukemia discovered during lymph node biopsy for melanoma. Ann Surg Oncol. November 2012.
Additional Publications
Dr. Jeffery Farma on PubMed
Jeffrey Farma, MD, FACS, Featured on Narratives of North Broad Podcast
Fox Chase Cancer Center’s Jeffrey Farma, MD, FACS, was guest speaker on the Narratives of North Broad Podcast - hosted by Lewis Katz School of Medicine student Hank Davis and Michael Vitez, Director of Temple's Narrative Medicine program.
Fox Chase’s Jeffrey Farma Admitted to Academy as Master Surgeon Educator
September 2, 2020—Fox Chase Cancer Center’s Jeffrey Farma, MD, FACS, was recently admitted to the prestigious American College of Surgeons Academy of Master Surgeon Educators.
Cancer Care During COVID-19
Cancer Care Turned Upside Down, by Jeffrey Farma MD, FACS, in the blog of the Association for Academic Surgery.
June 5, 2020
Related Articles
32 PATIENT COMMENTS
-
5.0
June 17, 2022
Dr. Farma was the nicest, most compassionate doctor that I have ever dealt with. Everyone at Fox Chase was outstanding.
-
5.0
June 11, 2022
Provider and staff were informative and extremely sensitive to my situation - could not have asked for any better attention - [...]
-
5.0
June 10, 2022
Everyone is great!!
-
5.0
May 31, 2022
The absolute best doctors/nurses/staff.
-
5.0
May 29, 2022
Very good experience
-
5.0
May 09, 2022
Dr. Farma is a talented, caring, sensitive doctor. He has a great bedside manner Would definitely recommend him.
-
5.0
May 04, 2022
G-d bless Dr. Farma. He is a gift. You are fortunate to have him on your medical staff.
-
5.0
May 02, 2022
My experience was excellent as usual with Dr. Farma & his staff.
-
4.5
May 02, 2022
This was my annual follow-up visit. Fortunately I'm doing well so there wasn't a lot to discuss. First I was seen by the physician assistant, who told the provider what she thought before he came in. I'm very satisfied with the care both have given me over the past 6 years.
-
5.0
April 30, 2022
Everything was excellent, except I wasn't seen for 1 hour and 45 minutes after my appointment time.
-
5.0
April 15, 2022
Dr. Farma is outstanding!
-
5.0
April 02, 2022
They are ALL ANGELS at Fox Chase & thank you for saving my life & many others GOD BLESS YOU ALL AT FOX CHASE
-
5.0
March 17, 2022
Fox Chase and Dr Farma saved my life and I'll be forever greatful.
-
5.0
February 22, 2022
I have all the confidence in the world with Dr. Farma & his staff.
-
5.0
February 14, 2022
Overall experience was very good...but it was only a 3-month follow-up checkup to make sure my surgery recovery was continuing well.
-
5.0
February 01, 2022
All-around excellent service and care by Dr. Farma and his staff.
-
5.0
January 03, 2022
It was a necessary visit to get more information about a prognosis. Despite that, everyone I came in contact with was extremely nice and caring, including volunteers and other employees that I didn't even meet withgave me a good feeling.
-
5.0
November 23, 2021
We are happy with the care being provided.
-
5.0
October 13, 2021
I was very satisfied with my visit. I was treated kindly and with respect. All my questions were answered in terms I understood. I left feeling well taken care of.
-
5.0
September 29, 2021
Dr. Farma is the best!!!!
LOAD MORE